CytoSorbents Corporation (OTC BB:CTSO) is an early revenue-stage, critical-care focused medical device company attempting to revolutionize the treatment of life-threatening illnesses in the intensive ...
Several Milestones Reached, Including Record Quarterly Revenue & Global Delivery of 110,000+ CytoSorb Cartridges To-Date Cytosorbents (NASDAQ:CTSO) reported 3Q20 revenue of $10.5 million last week, up ...
Replay the call for the latest insights. Loading chart for CTSO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results